Sol-Gel Technologies Ltd Stock, NASDAQ:SLGL
Weizmann Science Park, 7 Golda Meir Street, Ness Ziona, Tel Aviv 74036
Number of Employees: 65
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.